207 related articles for article (PubMed ID: 11390446)
1. A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis.
Christen U; Wolfe T; Möhrle U; Hughes AC; Rodrigo E; Green EA; Flavell RA; von Herrath MG
J Immunol; 2001 Jun; 166(12):7023-32. PubMed ID: 11390446
[TBL] [Abstract][Full Text] [Related]
2. Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearance.
von Herrath MG; Coon B; Wolfe T; Chatenoud L
J Immunol; 2002 Jan; 168(2):933-41. PubMed ID: 11777992
[TBL] [Abstract][Full Text] [Related]
3. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB
J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.
Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG
J Immunol; 1999 Nov; 163(10):5374-82. PubMed ID: 10553062
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis of autoreactive CD8 lymphocytes as a potential mechanism for the abrogation of type 1 diabetes by islet-specific TNF-alpha expression at a time when the autoimmune process is already ongoing.
Christen U; Von Herrath MG
Ann N Y Acad Sci; 2002 Apr; 958():166-9. PubMed ID: 12021099
[TBL] [Abstract][Full Text] [Related]
6. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
7. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
[TBL] [Abstract][Full Text] [Related]
9. Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocytic infiltration.
McKall-Faienza KJ; Kawai K; Kündig TM; Odermatt B; Bachmann MF; Zakarian A; Mak TW; Ohashi PS
Int Immunol; 1998 Apr; 10(4):405-12. PubMed ID: 9620596
[TBL] [Abstract][Full Text] [Related]
10. Enhanced T cell responses contribute to the genetic predisposition of CD8-mediated spontaneous autoimmunity.
Garza KM; McKall-Faienza KJ; Otheki T; Zakarian A; Odermatt B; Ohashi PS
Eur J Immunol; 2002 Mar; 32(3):885-94. PubMed ID: 11870633
[TBL] [Abstract][Full Text] [Related]
11. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
[TBL] [Abstract][Full Text] [Related]
13. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease.
Christen U; McGavern DB; Luster AD; von Herrath MG; Oldstone MB
J Immunol; 2003 Dec; 171(12):6838-45. PubMed ID: 14662890
[TBL] [Abstract][Full Text] [Related]
14. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts.
Vizler C; Bercovici N; Heurtier A; Pardigon N; Goude K; Bailly K; Combadière C; Liblau RS
J Immunol; 2000 Dec; 165(11):6314-21. PubMed ID: 11086068
[TBL] [Abstract][Full Text] [Related]
15. Protection from type 1 diabetes in the face of high levels of activated autoaggressive lymphocytes in a viral transgenic mouse model crossed to the SV129 strain.
von Herrath MG; Wolfe T; Möhrle U; Coon B; Hughes A
Diabetes; 2001 Dec; 50(12):2700-8. PubMed ID: 11723052
[TBL] [Abstract][Full Text] [Related]
16. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
[TBL] [Abstract][Full Text] [Related]
17. A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF.
Herrera PL; Harlan DM; Vassalli P
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):279-84. PubMed ID: 10618409
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
[TBL] [Abstract][Full Text] [Related]
19. IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse.
Fuchs YF; Adler K; Lindner A; Karasinsky A; Wilhelm C; Weigelt M; Balke H; Förtsch K; Mortler-Hildebrandt LF; Harlan DM; Pechhold K; Ziegler AG; Bonifacio E
Clin Exp Immunol; 2014 May; 176(2):199-206. PubMed ID: 24387268
[TBL] [Abstract][Full Text] [Related]
20. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes.
Rajagopalan G; Mangalam AK; Sen MM; Kudva YC; David CS
Autoimmunity; 2007 Nov; 40(7):489-96. PubMed ID: 17966038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]